Plasma Levels of Homocysteine is Associated with Liver Fibrosis in Health Check-Up Population
Dan Lv,1 Zepu Wang,2 Shuai Ji,1 Xiaoxi Wang,1 Huiqing Hou1 1Physical Examination Center, Hebei General Hospital, Shijiazhuang City, Hebei Province, People’s Republic of China; 2Department of Hepatobiliary Surgery, Hebei General Hospital, Shijiazhuang City, Hebei Province, People’s Republic of ChinaC...
| Published in: | International Journal of General Medicine |
|---|---|
| Main Authors: | Lv D, Wang Z, Ji S, Wang X, Hou H |
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2021-09-01
|
| Subjects: | |
| Online Access: | https://www.dovepress.com/plasma-levels-of-homocysteine-is-associated-with-liver-fibrosis-in-hea-peer-reviewed-fulltext-article-IJGM |
Similar Items
Diagnostic value of Transient Elastography (Fibroscan) in the evaluation of liver fibrosis in chronic viral hepatitis C: Comparison to liver biopsy
by: Mona El-Hariri, et al.
Published: (2017-06-01)
by: Mona El-Hariri, et al.
Published: (2017-06-01)
Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis
by: Giovanna Cuomo, et al.
Published: (2023-05-01)
by: Giovanna Cuomo, et al.
Published: (2023-05-01)
The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
by: Chia-Yen Dai, et al.
Published: (2022-06-01)
by: Chia-Yen Dai, et al.
Published: (2022-06-01)
Readily Available Index of Insulin Sensitivity Is Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes
by: Stefano Ciardullo, et al.
Published: (2025-06-01)
by: Stefano Ciardullo, et al.
Published: (2025-06-01)
The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers
by: Zahra Safari, et al.
Published: (2023-05-01)
by: Zahra Safari, et al.
Published: (2023-05-01)
Assessment of hepatic fibrosis in patients with rheumatoid arthritis on long-term methotrexate therapy using transient elastography
by: Abhishek Kumar, et al.
Published: (2018-01-01)
by: Abhishek Kumar, et al.
Published: (2018-01-01)
Comparison of Transient Elastography and Point Shear Wave Elastography for Analysis of Liver Stiffness: A Prospective Study
by: Giuseppe Losurdo, et al.
Published: (2024-03-01)
by: Giuseppe Losurdo, et al.
Published: (2024-03-01)
State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives
by: Adrian Huber, et al.
Published: (2015-01-01)
by: Adrian Huber, et al.
Published: (2015-01-01)
Chitinase 3-like protein 1: a diagnostic biomarker for early liver fibrosis in autoimmune liver diseases
by: Shafei Liu, et al.
Published: (2025-04-01)
by: Shafei Liu, et al.
Published: (2025-04-01)
HOMOCYSTEINЕ AFTER LIVER TRANSPLANTATION IN CHILDREN
by: O. P. Shevchenko, et al.
Published: (2012-12-01)
by: O. P. Shevchenko, et al.
Published: (2012-12-01)
The importance of elastography in hepatological diagnostics in children
by: Eliza Łężyk-Ciemniak, et al.
Published: (2025-03-01)
by: Eliza Łężyk-Ciemniak, et al.
Published: (2025-03-01)
The Accuracy of Ultrasound Controlled Attenuation Parameter in Diagnosing Hepatic Fat Content
by: Atzori S, et al.
Published: (2023-06-01)
by: Atzori S, et al.
Published: (2023-06-01)
Assessment of laboratory findings and liver elastography in patients with non-alcoholic fatty liver disease
by: Tarang Taghvaei, et al.
Published: (2023-12-01)
by: Tarang Taghvaei, et al.
Published: (2023-12-01)
Liver steatosis is positively associated with plasminogen activator inhibitor-1 in apparently healthy individuals with overweight and obesity: A FibroScan-Based Cross-Sectional study
by: Giuseppe Lisco, et al.
Published: (2025-04-01)
by: Giuseppe Lisco, et al.
Published: (2025-04-01)
Evaluating the non-invasive tools for assessment of liver fibrosis in children with intrahepatic cholestasis prior to partial biliary diversion: tertiary-center experience
by: Hadeer Mohamed Nasr El-din, et al.
Published: (2023-03-01)
by: Hadeer Mohamed Nasr El-din, et al.
Published: (2023-03-01)
Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents
by: Naim Abu-Freha, et al.
Published: (2023-09-01)
by: Naim Abu-Freha, et al.
Published: (2023-09-01)
Liver damage in patients hospitalized with acute decompensated heart failure, depending on the degree of glucose metabolism disorder
by: V. V. Tolkacheva, et al.
Published: (2024-10-01)
by: V. V. Tolkacheva, et al.
Published: (2024-10-01)
Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis
by: Leire Pérez-Latorre, et al.
Published: (2018-04-01)
by: Leire Pérez-Latorre, et al.
Published: (2018-04-01)
Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience
by: Thanikan Sukaram, et al.
Published: (2025-01-01)
by: Thanikan Sukaram, et al.
Published: (2025-01-01)
Non-invasive evaluation of liver stiffness in nonalcoholic fatty liver disease: supersonic shear imaging, FibroScan or ARFI?
by: Coskun Ozturker, et al.
Published: (2016-12-01)
by: Coskun Ozturker, et al.
Published: (2016-12-01)
Diagnostic value of serologic biomarkers for the detection of liver fibrosis in non-alcoholic fatty liver disease
by: Mahsa Mohammadi, et al.
Published: (2025-03-01)
by: Mahsa Mohammadi, et al.
Published: (2025-03-01)
Noninvasive Assessment of Nonalcoholic Fatty Liver Disease in Children with Overweight and Obesity by Transient Elastography
by: Mohamed Fajrudheen, et al.
Published: (2025-03-01)
by: Mohamed Fajrudheen, et al.
Published: (2025-03-01)
Prevalence of advanced liver fibrosis in the general population of the Paris region according to FIB-4 score and liver risk score
by: Henri Tran, et al.
Published: (2025-07-01)
by: Henri Tran, et al.
Published: (2025-07-01)
The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database
by: Naim Alkhouri, et al.
Published: (2022-07-01)
by: Naim Alkhouri, et al.
Published: (2022-07-01)
Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
by: Xinyu Yang, et al.
Published: (2021-03-01)
by: Xinyu Yang, et al.
Published: (2021-03-01)
Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease
by: Ankur Srivastava, et al.
Published: (2019-07-01)
by: Ankur Srivastava, et al.
Published: (2019-07-01)
Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study
by: Assim A Alfadda, et al.
Published: (2022-01-01)
by: Assim A Alfadda, et al.
Published: (2022-01-01)
Prevalence of Clinically Significant Liver Fibrosis as Measured by Transient Elastography due to Non-alcoholic Fatty Liver Disease in Indian Individuals with Type 2 Diabetes Mellitus
by: Rajat Deb
Published: (2024-08-01)
by: Rajat Deb
Published: (2024-08-01)
Innovative Elastography Measuring Cap for Ex Vivo Liver Condition Assessment: Numerical and Preclinical Studies in a Porcine Model
by: Dariusz Pyka, et al.
Published: (2025-01-01)
by: Dariusz Pyka, et al.
Published: (2025-01-01)
Identification of high-risk subjects in nonalcoholic fatty liver disease
by: Christiane Stern, et al.
Published: (2023-02-01)
by: Christiane Stern, et al.
Published: (2023-02-01)
Prediction of oesophageal varices in cirrhotic patients by measuring liver stiffness with fibroscan
by: Shahinul Alam, et al.
Published: (2016-08-01)
by: Shahinul Alam, et al.
Published: (2016-08-01)
Hepatic fibrosis in morbidly obese patients: fibroscan accuracy
by: Maged Tharwat Elghannam, et al.
Published: (2025-05-01)
by: Maged Tharwat Elghannam, et al.
Published: (2025-05-01)
Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study
by: Abo-Amer YEE, et al.
Published: (2020-03-01)
by: Abo-Amer YEE, et al.
Published: (2020-03-01)
Liver stiffness and serum galectin 3 level significantly increases in patients with prediabetes: a fibroscan study
by: Huseyin Ali Ozturk, et al.
Published: (2025-04-01)
by: Huseyin Ali Ozturk, et al.
Published: (2025-04-01)
Folate alleviated skin inflammation and fibrosis resulting from impaired homocysteine metabolism
by: Jiefeng Huang, et al.
Published: (2025-03-01)
by: Jiefeng Huang, et al.
Published: (2025-03-01)
The Effect of Chronic liver diseases on homocysteine and vitamin B12 in patients serum
by: Essam F. Al-Jumaily, et al.
Published: (2010-01-01)
by: Essam F. Al-Jumaily, et al.
Published: (2010-01-01)
Plasma homocysteine levels in patients with Psoriasis
by: Mousumi Das
Published: (2017-08-01)
by: Mousumi Das
Published: (2017-08-01)
THE CORRELATION BETWEEN THE ESTIMATED NON-INVASIVE LIVER FIBROSIS AND VARIOUS CLINICAL, BIOLOGICAL AND IMAGING PARAMETERS IN CHRONIC VIRAL HEPATOPATHY
by: Cristina Olariu, et al.
Published: (2018-03-01)
by: Cristina Olariu, et al.
Published: (2018-03-01)
The level of plasma homocysteine in patients with non-alcoholic fatty liver disease in combination with type 2 diabetes
by: V. F. Orlovskiy, et al.
Published: (2015-06-01)
by: V. F. Orlovskiy, et al.
Published: (2015-06-01)
A study on outcome of hepatic fibrosis in chronic hepatitis B patients on anti-viral therapy
by: Avick Nag, et al.
Published: (2024-02-01)
by: Avick Nag, et al.
Published: (2024-02-01)
Similar Items
-
Diagnostic value of Transient Elastography (Fibroscan) in the evaluation of liver fibrosis in chronic viral hepatitis C: Comparison to liver biopsy
by: Mona El-Hariri, et al.
Published: (2017-06-01) -
Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis
by: Giovanna Cuomo, et al.
Published: (2023-05-01) -
The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
by: Chia-Yen Dai, et al.
Published: (2022-06-01) -
Readily Available Index of Insulin Sensitivity Is Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes
by: Stefano Ciardullo, et al.
Published: (2025-06-01) -
The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers
by: Zahra Safari, et al.
Published: (2023-05-01)
